Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
2
×
national blog main
20/20 healthcare partners
abbvie
acorda therapeutics
amgen ventures
ampyra
amyotrophic lateral sclerosis
anthony despasqua
apokyn
apomorphine
biotech
boston
christian angermayer
clinical trials
dalfampridine
dolby family ventures
duopa
enclear therapies
financing
funding
gf securities
global health sciences fund
hillel bachrach
inbrija
jason camm
karimah es sabar
labcentral
medical device
mylan
national top stories
new york
new york blog main
new york top stories
parkinson's disease
paul matteis
peter thiel
presight capital
What
disease
2
×
new
working
2
×
acorda
approved
associated
companies
cope
develop
device
dialysis
diseases
drug
drugs
enclear
episodes
fda
friday
gets
harmful
help
late
looms
meant
medications
nets
neuro
neurodegenerative
nod
parkinson’s
patients
proteins
raised
rival
stop
target
test
therapies
treatment
Language
unset
Current search:
working
×
disease
×
" life sciences "
×
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms